# A Trial of Everolimus and Bevacizumab in Children With Recurrent Solid Tumors

> **NCT00756340** · PHASE1 · COMPLETED · sponsor: **St. Jude Children's Research Hospital** · enrollment: 16 (actual)

## Conditions studied

- Recurrent or Refractory Solid Tumors
- CNS Malignancies

## Interventions

- **DRUG:** Bevacizumab
- **DRUG:** Everolimus

## Key facts

- **NCT ID:** NCT00756340
- **Lead sponsor:** St. Jude Children's Research Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-07
- **Primary completion:** 2015-09
- **Final completion:** 2015-09
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2015-10-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00756340

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00756340, "A Trial of Everolimus and Bevacizumab in Children With Recurrent Solid Tumors". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00756340. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*